The Health Care Select Sector SPDR Fund (XLV) has moved into a short-term downtrend after reaching a peak near 160 earlier this year. In my view, the price action over the last 30 days reflects a decline of about 0.60%, with a steeper 5.74% drop over the past quarter. Recently, the ETF tested lows around 142 before pulling back slightly to current levels near 144-145. This comes after a breakdown from higher levels, leaving price below multiple short-term moving averages. While the longer-term structure holds some constructive elements following a break of a descending trendline earlier, the recent weakness has me watching closely for signs of continuation or a potential reversal.
From what I see, traders are honing in on nearby pivot levels based on recent price action. Classical pivots indicate immediate support at S1 144.43, S2 144.04, and S3 143.80, with resistance at R1 145.06, R2 145.30, and R3 145.69. On a broader chart, stronger support lies in the 125-130 zone, where institutional absorption has occurred, and resistance clusters near 137.5-138, with an unfilled gap around 140 that could draw price higher on any upside move. Holding above 144 might help stabilize things, but a breach below could lead to deeper tests.
The moving averages largely signal sell, with 11 out of 12 showing bearish readings. The 5-day MA is at 144.56 (simple), the 20-day ranges from 145.13-145.94, the 50-day from 144.86-148.34, and the 200-day at 146.24-147.23. With price trading below these levels, the downtrend is confirmed, though the closeness to shorter MAs hints at possible consolidation. I think a crossover above the 20-day would mark the first bullish shift worth noting.
RSI(14) is holding in neutral territory around 44-46 across sources, steering clear of oversold levels below 30. The MACD(12,26) at -0.06 with a sell signal highlights bearish divergence. Stochastic indicators also tilt toward sell, with STOCH(9,6) at 21.45 and Williams %R at -74 signaling downward pressure. Overall, the oscillators align with a strong sell rating, consistent with the technical summary.
Recent daily volume has averaged 8-12 million shares, with the latest session at 7.4 million and no unusual spikes. Volume has tracked the price decline without picking up speed, which points to orderly selling rather than panic. The 20-day average volume sits around 8.4 million, reflecting steady activity in this defensive sector ETF. One thing that stands out is how this controlled volume supports the current consolidation.
In my analysis, I’ve found Tickeron’s AI Daily Buy/Sell Signals particularly useful for digging deeper into XLV. These signals use artificial intelligence to analyze vast datasets, including technical indicators, price patterns, and historical trends. They help spot potential buy or sell opportunities by identifying recurring market behaviors, momentum shifts, and anomalies that might escape traditional methods. I rely on them to refine entry and exit points, confirm trend strength, and make better decisions in choppy markets. Updated daily, they add an objective edge to my chart work—worth checking out if you’re building AI-driven insights into your own strategy.
This is important because market participants are focused on potential stabilization near 144 support, where a break above 145.30 resistance could bring short-term relief. Deeper support at 125-130 might draw buyers if tested, though failure there could expose the 127.35 52-week low. I’m watching RSI for any oversold bounces and MACD for histogram changes. Clearing the 137.5-140 gap on the upside would aim for prior highs, but trades sustained below 144 suggest further downside. Volatility is moderate, so volume confirmation around these levels will be key.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
XLV saw its Momentum Indicator move above the 0 level on May 18, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned positive. In of the 93 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for XLV just turned positive on May 12, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
XLV moved above its 50-day moving average on June 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for XLV crossed bullishly above the 50-day moving average on May 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 267 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for XLV moved out of overbought territory on June 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for XLV moved below the 200-day moving average on May 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
XLV broke above its upper Bollinger Band on June 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category Health